Undervirilized male syndrome

From WikiMD's WELLNESSPEDIA

Undervirilized Male Syndrome Undervirilized Male Syndrome (UMS) is a rare condition characterized by incomplete masculinization of a genetically male individual. This condition can result from various genetic, hormonal, or environmental factors that affect the development of male physical characteristics.

Etiology[edit]

The causes of Undervirilized Male Syndrome can be diverse, including:

Pathophysiology[edit]

UMS occurs when there is a disruption in the normal process of male sexual differentiation. This can happen due to:

  • Insufficient production of testosterone
  • Impaired conversion of testosterone to dihydrotestosterone (DHT)
  • Defective androgen receptors

Clinical Features[edit]

Individuals with UMS may present with a range of symptoms, including:

  • Ambiguous genitalia
  • Micropenis
  • Hypospadias
  • Cryptorchidism
  • Gynecomastia

Diagnosis[edit]

Diagnosis of UMS involves:

  • Detailed medical history and physical examination
  • Hormonal assays to measure levels of testosterone, DHT, and other relevant hormones
  • Genetic testing to identify mutations
  • Imaging studies such as ultrasound or MRI

Management[edit]

Management of UMS is multidisciplinary and may include:

  • Hormone replacement therapy
  • Surgical correction of genital anomalies
  • Psychological support and counseling

Prognosis[edit]

The prognosis for individuals with UMS varies depending on the underlying cause and the effectiveness of treatment. Early diagnosis and intervention can improve outcomes.

See Also[edit]

External Links[edit]

NIH genetic and rare disease info[edit]

Undervirilized male syndrome is a rare disease.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.